Cardiometabolic Effects of Irisin in Patients with End-Stage Renal Disease on Regular Hemo- or Peritoneal Dialysis
Conclusions: Our study demonstrated that serum irisin levels are reduced in uremic patients on regular HD/PD but failed to establish significant associations of irisin deficiency with vascular stiffness. However, the significant negative relationship of irisin to HbA1c, iPTH, and alkaline phosphatase suggests that it improves insulin sensitivity, inhibits bone resorption, mitigates bone-vascular interaction, and protects vascular function.Blood Purif
Source: Blood Purification - Category: Hematology Source Type: research
More News: Australia Health | Carbohydrates | Cardiology | Cardiovascular | Czechia Health | Depression | Dialysis | Heart | Hematology | Hemodialysis | Insulin | Laboratory Medicine | Peritoneal Dialysis | Study